X
Record #20088

Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

Original paper date
Mar 15, 2011
Institution
Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, 08908 L'Hospitalet, Barcelona, Catalonia, Spain · Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, 08908 L'Hospitalet Barcelona, Catalonia, Spain · Departments of Experimental Therapeutics and Cancer Genetics, M D Anderson Cancer Center, Houston, TX 77030 · Bioinformatics Core Facility, CH-1015 Lausanne, Switzerland · Department of Pathology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute, 08907 L'Hospitalet de Llobregat, Barcelona, Spain · Departamento de Bioquímica y Biología Molecular, Universidad de Alcalá, Alcalá de Henares, 28801 Alcalá de Henares, Madrid, Spain · Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215 · Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210 · Institucio Catalana de Recerca i Estudis Avançats, 08010 Barcelona, Catalonia, Spain
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cancer(BLS) Biology - Cellular(BLS) Genetics
Citation lifecycle

How this paper is being cited

Pre-retraction
242
Same day
1
Post-retraction
246
% post-retraction
96.9%
~41.4 citations/yr before retraction · ~25.5 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse